Evidence map

ArticleCureus2025

Saroglitazar Versus Simvastatin for Metabolic and Alcohol-Associated Liver Disease (MetALD).

Anand Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40642726